DV Investments provides venture capital to early-stage companies across life sciences, health technology & services, and animal health with the goal of supporting our portfolio companies throughout their development.
We invest in biotechnology companies leveraging breakthrough science to improve human health. Our interests encompass a broad spectrum of the life sciences, from therapeutics and diagnostics to tools and enabling technologies.
We invest in companies building novel technology-enabled solutions to improve access to care and health outcomes while reducing costs to individuals and the healthcare system.
Through our Companion Funds, we invest in companies leveraging breakthrough science, technology, and design to improve animal health. In partnership with Mars Petcare, the industry leader spanning veterinary care, nutrition, diagnostics, wearable health, DNA testing and pet welfare, we provide operational experience and growth capital to founders across stages.
Our relationship with Mars Petcare allows our investment syndicate partners and startup leadership teams to access the knowledge and power of:
More than 70,000 Associates in veterinary services and diagnostics, caring for more than 25 million pets each year across 2,500+ clinics and labs
A truly global footprint improving the lives of animals, with presence and operational experience in more than 130 countries
And the combined expertise of high quality, science-backed nutrition and therapeutic health products, designed to improve outcomes in animal health
For founders at the earliest stages, please apply for our accelerator in partnership with Michelsen Found Animals and R/GA Ventures at Leap Venture Studio. To dive further into our views on innovation in Animal Health, as well as its relation to and impact upon human health, read this piece on One Health.